Suppr超能文献

终末期肾病患者对腺苷的心率反应与死亡率之间的关系。

Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease.

作者信息

Venkataraman Rajesh, Hage Fadi G, Dorfman Todd A, Heo Jaekyeong, Aqel Raed A, de Mattos Angelo M, Iskandrian Ami E

机构信息

University of Alabama at Birmingham, USA.

出版信息

Am J Cardiol. 2009 Apr 15;103(8):1159-64. doi: 10.1016/j.amjcard.2009.01.007. Epub 2009 Mar 4.

Abstract

This study examined the relation between heart rate (HR) response to adenosine and outcome in patients with end-stage renal disease (ESRD). The usual HR increase during adenosine infusion was caused by direct sympathetic stimulation. It was hypothesized that a blunted HR response, which was probably caused by sympathetic denervation, would be associated with a worse outcome in patients with ESRD. One hundred thirty-nine patients with ESRD being evaluated for renal transplantation who underwent coronary angiography and adenosine gated single-photon emission computed tomographic myocardial perfusion imaging were followed up for all-cause mortality. Percentage of change in HR (%DeltaHR) was calculated as [(peak HR during adenosine infusion - HR at rest)/HR at rest] * 100. A control group of 54 patients (normal renal function and no diabetes) was included for comparison of HR responses. Mean age of patients was 54 +/- 9 years, 30% were women, and 68% had type-2 diabetes mellitus. %DeltaHR was 19.2 +/- 18% in patients with ESRD versus 33 +/- 25% in the control group (p <0.0001). At a mean follow-up of 3.4 +/- 1.5 years, 50 patients (36%) with ESRD died. %DeltaHR was lower in nonsurvivors than survivors (12.6 +/- 14% vs 23 +/- 19%; p = 0.0017). Patients with %DeltaHR less than the median value were more likely to have lower left ventricular ejection fraction and larger end-diastolic volume (p <0.05 for each). In a multivariate logistic regression model, %DeltaHR alone was an independent predictor of all-cause mortality (adjusted odds ratio 5.5, 95% confidence interval 2.3 to 12.9, p = 0.0001). In conclusion, patients with ESRD had a blunted HR response to adenosine, and degree of blunting was strongly associated with all-cause mortality.

摘要

本研究探讨了终末期肾病(ESRD)患者对腺苷的心率(HR)反应与预后之间的关系。腺苷输注期间常见的心率增加是由直接的交感神经刺激引起的。据推测,可能由交感神经去神经支配导致的心率反应迟钝与ESRD患者较差的预后相关。对139例接受肾移植评估的ESRD患者进行了冠状动脉造影和腺苷门控单光子发射计算机断层心肌灌注成像,并对其全因死亡率进行了随访。心率变化百分比(%ΔHR)计算为[(腺苷输注期间的峰值心率 - 静息心率)/静息心率]×100。纳入了54例患者的对照组(肾功能正常且无糖尿病)以比较心率反应。患者的平均年龄为54±9岁,30%为女性,68%患有2型糖尿病。ESRD患者的%ΔHR为19.2±18%,而对照组为33±25%(p<0.0001)。在平均随访3.4±1.5年时,50例(36%)ESRD患者死亡。非幸存者的%ΔHR低于幸存者(12.6±14%对23±19%;p = 0.0017)。%ΔHR低于中位数的患者更可能有较低的左心室射血分数和较大的舒张末期容积(每项p<0.05)。在多变量逻辑回归模型中,单独的%ΔHR是全因死亡率的独立预测因素(调整后的优势比为5.5,95%置信区间为2.3至12.9,p = 0.0001)。总之,ESRD患者对腺苷的心率反应迟钝,且迟钝程度与全因死亡率密切相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验